Nanobody-based chimeric antibodies target fluorescent and structural proteins.
Read More
Pioneering biotechnology firm Horizon Proteins has appointed Iain Lochhead Chief Executive Officer in a boardroom reshuffle to support its growth plans. The strategic changes will also see co-founder Nik Willoughby become Chief Technology Officer.
Read More
Companies approach £750 million and are on course to surpass 2025 target of £900 million. Scotland’s industrial biotechnology companies are exceeding growth expectations and now deliver combined revenues of nearly £750 million, according to figures that will be announced at #IBioIC21.
Read More
Scotland’s internationally renowned technology and skills in industrial biotechnology could be further harnessed to fight against Covid-19, attendees at one of the world’s leading events on the subject will hear.
Read More